Clinical Trial Update: A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating boron neutron capture therapy using boron-10 labeled L-BPA for malignant brain tumors. The study is sponsored by China Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• L-BPA (boronophenylalanine)

Snippet

Sponsor: China Medical University Hospital | Conditions: Malignant Brain Tumors | Phase 1, Phase 2 | Status: RECRUITING